Literature DB >> 16747480

On the chemistry of heparin.

E Jorpes1.   

Abstract

Entities:  

Year:  1942        PMID: 16747480      PMCID: PMC1265675          DOI: 10.1042/bj0360203

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  5 in total

1.  The polysaccharide content and reducing power of proteins and of their digest products.

Authors:  L F Hewitt
Journal:  Biochem J       Date:  1938-09       Impact factor: 3.857

2.  Observations on the structure of the barium salt of heparin.

Authors:  A F Charles; A R Todd
Journal:  Biochem J       Date:  1940-01       Impact factor: 3.857

3.  The chemistry of heparin.

Authors:  E Jorpes
Journal:  Biochem J       Date:  1935-08       Impact factor: 3.857

4.  Studies on heparin: Observations on the chemistry of heparin.

Authors:  A F Charles; D A Scott
Journal:  Biochem J       Date:  1936-10       Impact factor: 3.857

5.  THE HEPARINS OF VARIOUS MAMMALIAN SPECIES AND THEIR RELATIVE ANTI-COAGULANT POTENCY.

Authors:  L B Jaques
Journal:  Science       Date:  1940-11-22       Impact factor: 47.728

  5 in total
  4 in total

1.  The determination of glucosamine and galactosamine.

Authors:  C J RONDLE; W T MORGAN
Journal:  Biochem J       Date:  1955-12       Impact factor: 3.857

2.  The virulence-enhancing factor of mucins. VI. Identification of a heparin as the main component of the third factor involved in virulence enhancement.

Authors:  H SMITH; R C GALLOP; P W HARRIS-SMITH; J L STANLEY
Journal:  Biochem J       Date:  1952-09       Impact factor: 3.857

3.  The virulence-enhancing factor of mucins. V. The different components of the third factor involved in virulence enhancement.

Authors:  H SMITH; R C GALLOP; J L STANLEY
Journal:  Biochem J       Date:  1952-09       Impact factor: 3.857

Review 4.  From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods.

Authors:  Jan-Ytzen van der Meer; Edwin Kellenbach; Leendert J van den Bos
Journal:  Molecules       Date:  2017-06-21       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.